SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,375,000 | +22.9% | 8,134,926 | 0.0% | 3.69% | +39.3% |
| Q4 2019 | $2,747,000 | -28.6% | 8,134,926 | +52.2% | 2.65% | -38.9% |
| Q3 2019 | $3,848,000 | +100.1% | 5,345,826 | +102.0% | 4.34% | +98.7% |
| Q2 2019 | $1,923,000 | +470.6% | 2,645,826 | +854.3% | 2.18% | +597.8% |
| Q1 2019 | $337,000 | +51.8% | 277,245 | +149.3% | 0.31% | +52.7% |
| Q3 2018 | $222,000 | +115.5% | 111,217 | +128.3% | 0.20% | +469.4% |
| Q2 2018 | $103,000 | – | 48,707 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,125,000 | $4,505,000 | 0.51% |
| DAFNA Capital Management LLC | 373,702 | $792,000 | 0.37% |
| BVF INC/IL | 1,684,636 | $3,571,000 | 0.35% |
| OIKOS HOLDINGS LLC | 182,395 | $387,000 | 0.24% |
| Eventide Asset Management | 2,265,455 | $4,803,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 512,036 | $1,086,000 | 0.17% |
| NEA Management Company, LLC | 1,298,274 | $2,752,000 | 0.13% |
| Palo Alto Investors LP | 1,162,473 | $2,464,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 427,642 | $907,000 | 0.09% |
| Telemetry Investments, L.L.C. | 90,781 | $192,000 | 0.07% |